Health Canada drug identification number

DIN 02245777 — VALCYTE 450 MG

VALCYTE is a tablet of Valganciclovir marketed by CHEPLAPHARM ARZNEIMITTEL GMBH. The full Valganciclovir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02245777
Brand name
VALCYTE
Active ingredient
Valganciclovir
Strength
450 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
CHEPLAPHARM ARZNEIMITTEL GMBH
Health Canada status
MARKETED
Drug class
Antiviral agent (ganciclovir prodrug, DNA polymerase inhibitor)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Valganciclovir products

DINBrandStrengthFormManufacturerStatus
02393824 APO-VALGANCICLOVIR 450 MG TABLET APOTEX INC DORMANT
02435179 AURO-VALGANCICLOVIR 450 MG TABLET AURO PHARMA INC MARKETED
02535483 AURO-VALGANCICLOVIR 50 MG POWDER FOR SOLUTION AURO PHARMA INC MARKETED
02495457 MINT-VALGANCICLOVIR 450 MG TABLET MINT PHARMACEUTICALS INC MARKETED
02413825 TEVA-VALGANCICLOVIR 450 MG TABLET TEVA CANADA LIMITED MARKETED
02306085 VALCYTE 50 MG POWDER FOR SOLUTION CHEPLAPHARM ARZNEIMITTEL GMBH MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.